Literature DB >> 8457379

HTLV-II infection in Florida Indians.

P H Levine1, S Jacobson, R Elliott, A Cavallero, G Colclough, C Dorry, C Stephenson, R M Knigge, J Drummond, M Nishimura.   

Abstract

A significantly increased prevalence of antibodies to human T-cell leukemia virus (HTLV) has been described in several native American populations in the United States and Latin America. Initial virologic studies indicate that HTLV-II is the predominant virus responsible for this antibody pattern. We obtained blood samples from 106 Seminole Indians living on four reservations in Southern Florida. Seropositivity to HTLV-I/II was found in 14 (13.2%) of these individuals. Polymerase chain reaction (PCR) documented HTLV-II and the absence of HTLV-I in 7 of the 9 donors available for follow-up testing of white blood cells. Evaluation of various risk factors excluded blood transfusion or intravenous drug use as an important contributing factor to the HTLV-II seroprevalence rate. These studies support the hypothesis that HTLV-II is endemic in many native American tribes in the Western hemisphere.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457379     DOI: 10.1089/aid.1993.9.123

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  19 in total

Review 1.  Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors:  Gerold Feuer; Patrick L Green
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies.

Authors:  R Ishak; A C R Vallinoto; V N Azevedo; A C P Vicente; W W Hall; M O G Ishak
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

Review 3.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

4.  Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.

Authors:  D Agranoff; K Varney; H Khayam-Bashi; E L Murphy
Journal:  West J Med       Date:  1996-06

5.  Identification and characterization of an extended Tax protein in human T-cell lymphotropic virus type II subtype b isolates.

Authors:  D Pardi; J E Kaplan; J E Coligan; T M Folks; R B Lal
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Prevalence of HTLV types I and II among drug users in King County, Washington.

Authors:  H Thiede; N V Harris; J P McGough; B Roberts; R F Khabbaz; J E Kaplan
Journal:  West J Med       Date:  1994-06

8.  Virologic and genetic studies relate Amerind origins to the indigenous people of the Mongolia/Manchuria/southeastern Siberia region.

Authors:  J V Neel; R J Biggar; R I Sukernik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

Authors:  W M Switzer; D Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; J E Kaplan; R B Lal; W Heneine
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb.

Authors:  W M Switzer; S M Owen; D A Pieniazek; V R Nerurkar; E Duenas-Barajas; W Heneine; R B Lal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.